On Monday, Tandem Diabetes Care Inc (TNDM) stock saw a modest uptick, ending the day at $31.37 which represents a slight increase of $0.77 or 2.52% from the prior close of $30.6. The stock opened at ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Waters (WAT – Research Report), Pharvaris ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price objective lowered by Canaccord Genuity Group from $57.00 to ...

On Friday, Tandem Diabetes Care Inc (TNDM) stock saw a decline, ending the day at $30.6 which represents a decrease of $-2.72 or -8.16% from the prior close of $33.32. The stock opened at $33.71 and ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Susan Morrison; Executive Vice President, Chief Administrative Officer; Tandem Diabetes Care Inc John Sheridan; President, Chief Executive Officer, Director; Tandem Diabetes Care Inc Leigh Vosseller; ...

Tandem Diabetes Care Inc (TNDM) achieves highest quarterly sales in history, driven by strong US and international growth, ...

Fintel reports that on November 6, 2024, Bernstein initiated coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...